-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Moderna to Present at Upcoming Conference in November 2026
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
SNZweig Forms AEC Industry Advisory Council
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
-
Kalm with Kava and Pū'iwa Farms Hawai'i Bring Fresh Frozen Hawaiian Kava to Market
-
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
-
Berwyn Group Launches BerwynAPI, Bringing Real-Time Death Confirmation to a Broad Variety of Industries Including Financial Services, Insurance and Healthcare
-
Team Montlick Wins Class 2 World Championship Title in Key West
From deadly rave to recovery: Israeli study examines MDMA's effect on trauma
Artillery fire echoed from nearby Gaza as Shye Klein-Weinstein slowly walked around a memorial honouring the nearly 400 people killed at the Nova music festival in Reim, southern Israel, on October 7, 2023.
The 28-year-old photographer and survivor of Hamas's attack recalled names and events from that fateful day -- some of which he captured on film, documenting the final moments of his fellow revellers.
Klein-Weinstein, an immigrant from Canada who had arrived in Israel just four months prior to the attack, also recalled another detail from the festival: taking ecstasy.
While still visibly shaken by the horrific experience, early findings from a study by researchers at Israel's Haifa University suggest that the MDMA Klein-Weinstein and others at the festival took that night may have been helpful in cushioning the impact of the trauma they endured.
"I came to the Nova with my cousin and several friends... It was my first music festival ever," Klein-Weinstein told AFP.
They "each took a half or a quarter pill of ecstasy", he said, going on to describe the unfolding chaos and his frantic escape.
- New findings -
The Haifa University study, which monitored 657 Nova survivors -- both those who took drugs and those who did not -- found in initial results that individuals under the influence of MDMA exhibited "significantly improved intermediate outcomes compared to those who were under the influence of other substances or no substances at all".
The study, which was recently accepted for publication in the World Psychiatry journal, noted that "the MDMA group reported increased feelings of social support, more social interactions and enhanced quality of sleep" after the event, "yielding reduced levels of mental distress and reduced PTSD symptom severity".
"That is a very unique finding -- it was never reported before, because it was never studied before, because it never happened before," said Roee Admon, one of the study's lead researchers.
Admon explained that while trauma research is well established, the attack on a gathering like the Nova festival has opened a new window into the effects of trauma under the influence of mind-altering substances.
"We don't know anything about the response to trauma when people, during the attack or traumatic event, are under the influence of specific substances like cannabis, alcohol, and psychedelics like LSD and MDMA," he said, adding that such a mass trauma event, where around 4,000 people were exposed to the same elements at the same time, is rare.
"I would feel like if something like that happened to me, I would want to be as much in control as possible, clean from any foreign influences or substances," said Admon. "But that's not what we found, and that's why it was very surprising."
Still, Admon was quick to caution that while MDMA may have offered a psychological buffer, the overall levels of PTSD among Nova survivors remained extremely high.
He also noted that the study was limited by "survivor bias", as researchers cannot learn from those killed in the attack.
- 'Love drug' -
At the Nova memorial, Klein-Weinstein said he is still struggling with trauma and has been undergoing therapy. Still, he believes the MDMA he took that night may have eased his symptoms somewhat.
But, he added, he did not want people to think MDMA "saved us or protected us... I don't know anybody who didn't die because they were on MDMA. They were just as vulnerable as anyone else, and we were all in the same situation."
Still, he continued, ecstasy is "known as the love drug. It makes you just want to hug your friends and dance and laugh and smile."
"When everything was happening, I noticed that I wasn't really afraid for myself," he recalled.
"The only concern I had was that I wouldn't be able to help my friends or that something would happen to them, and I would be totally useless, unable to do anything -- that was a terrible feeling, not being in control."
Vered Atzmon-Meshulam, a psychologist specialising in trauma and head of the Resilience Division at the rescue and recovery organisation ZAKA, told AFP she was not surprised by the study because previous research has suggested MDMA could help treat post-traumatic stress disorder
In 2023, Australia became the first country to legalise the use of MDMA to treat PTSD.
"This research is very important for continuing to develop tailored responses for extreme trauma," Atzmon-Meshulam said.
"We must move forward to the next phase, which includes treatments that use psychedelics for healing in a true and widespread manner, not just for the people who were at Nova, but many others who suffer from post-trauma."
F.Dubois--AMWN